India licenses generic copy of patented Bayer drug
Monday, March 12, 2012 - 15:20
in Mathematics & Economics
NEW DELHI (AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable....